Transurethral bipolar plasmakinetic resection of the prostatefor the treatment of benign prostatic hyperplasia

Objective To evaluate the safety and efficacy of transurethral bipolar plasmakinetic resection of the prostate (TUPKRP)for the treatment of benign prostatic hyperplasia(BPH).Methods 238 cases of benign prostatic hyperplasia were treated with transurethral bipolar plasmakinetic resection of the prostate.Results The duration of the procedure was 35-195(67±45)min.No obturator reflex or transurethral resection syndrome occurred and the blood loss was low during operation.226 patients had been followed up for 6 to 12 months, and the international prostate symptom score(IPSS)decreased from(24.3±6.4) preoperatively to (13.9±5.6) postoperatively.The scores of quality of life(QOL)decreased from(4.1±0.9) preoperatively to (1.5±0.2)postoperatively.The residual urine volume (RUV) decreased from (96±82)ml preoperatively to (15±7) ml postoperatively.4 cases of external urethral stricture and no cases of posterior urethral stricture and no cases of permanent incontinence of urine were found.Conclusion Transurethral bipolar plasmakinetic resection of the prostate for thetreatment of benign prostatic hyperplasia is effective and safe with few complications and general indications.